Exhibit 99.1

RESEARCH TRIANGLE PARK, N.C.-- July 12, 2006--Embrex(R), Inc., The In Ovo
Company(R), (Nasdaq:EMBX) announced Embrex management intends to file its Second
Quarter 2006 Form 10-Q and issue its financial press release on Monday, August
7, 2006. Embrex's management, led by President and CEO Randall L. Marcuson, will
further discuss these financial results in a conference call on Tuesday, August
8, at 11:00 a.m. ET. To join the conference call, dial (800) 446-9604 (domestic
and Canada), or (706) 643-5312 (international), identify Randall Marcuson or Don
Seaquist as the conference leader, and if asked, provide conference
identification number 3019636.

This call is being webcast by Thomson/CCBN and can be accessed at Embrex's web
site at www.embrex.com. Click on the Investor Info button to access the link.

The webcast is also being distributed over Thomson/CCBN's Investor Distribution
Network to both institutional and individual investors. Individual investors can
listen to the call through Thomson/CCBN's individual investor center at
www.earnings.com or by visiting any of the investor sites in Thomson/CCBN's
Individual Investor Network. Institutional investors can access the call via
Thomson/CCBN's password-protected event management site, StreetEvents
(www.streetevents.com).

A telephone replay will be available from approximately 2 p.m. ET August 9 to
midnight ET August 23 by dialing (800) 642-1687 (domestic and Canada), or (706)
645-9291 (international), conference ID 3019636.

Embrex(R), Inc., The In Ovo Company(R), is an international agricultural
biotechnology company engaged in the development of innovative in ovo (in the
egg) solutions that meet the needs of today's global poultry industry.

Embrex(R) and The In Ovo Company(R) are trademarks of Embrex, Inc.

Contact: Don Seaquist
Phone:   919-941-5185

                                    -- end --